Login / Signup
Chenggong Li
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 3
Top Topics
Drug Delivery
Multiple Myeloma
Histone Deacetylase
Phase Ii
Top Venues
Therapeutic advances in hematology
Leukemia
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Chenggong Li
,
Xindi Wang
,
Jia Xu
,
Jiachen Liu
,
Heng Mei
Treatment of multiple myeloma: What is the impact on T-cell function?
Therapeutic advances in hematology
15 (2024)
Chenggong Li
,
Xindi Wang
,
Jia Xu
,
Jiachen Liu
,
Heng Mei
Treatment of multiple myeloma: What is the impact on T-cell function?
Therapeutic advances in hematology
15 (2024)
Chenggong Li
,
Jia Xu
,
Wenjing Luo
,
Danying Liao
,
Wei Xie
,
Qiuzhe Wei
,
Yinqiang Zhang
,
Xindi Wang
,
Zhuolin Wu
,
Yun Kang
,
Jin'e Zheng
,
Wei Xiong
,
Jun Deng
,
Han Yan
,
Heng Mei
Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma.
Leukemia
(2023)